Novo Nordisk A/S
(NYSE: NVO)
|
8:00 PM UTC, 05/17/24 | |||
---|---|---|---|---|
Last: $131.89 | Change: -1.15 | %Change: -0.86% | Volume: 2,590,304 |
Ratio | Ex-Date1 | Payable2 | Record3 | Declaration4 |
---|---|---|---|---|
2-1 | 20-Sep-23 | 19-Sep-23 | 14-Sep-23 | 10-Aug-23 |
2-1 | 30-Nov-02 | 10-Jul-14 | 30-Jun-14 | n/a |
5-1 | 9-Jan-14 | 8-Jan-14 | 3-Jan-14 | n/a |
2-1 | 17-Dec-07 | 14-Dec-07 | 30-Nov-07 | n/a |
5-2 | 11-Apr-01 | 10-Apr-01 | 6-Apr-01 | n/a |
4-1 | 18-Apr-94 | 15-Apr-94 | 8-Apr-94 | n/a |
1. Investors who purchase a stock on or after its Ex-Date do not receive the dividend payment for the
prior period.
2. Date on which a declared dividend is paid.
3. Date on which a shareholder must own the stock in order to qualify for a dividend payment. Date
relevant for registered DR holders.
4. Date on which a company announces the amount and date of its dividend payment.
Period | Eps Estimate |
Eps Actual |
Prev-Year Actual |
Date/Time (ET) |
---|---|---|---|---|
Q1 2024 | 0.75 | 0.81 | 0.65 | 31-Mar-24 |
Q4 2023 | 0.67 | 0.72 | 0.43 | 31-Dec-23 |
Q3 2023 | 0.68 | 0.71 | 0.42 | 30-Sep-23 |
Q2 2023 | 0.68 | 0.64 | n.a. | 30-Jun-23 |
Period | Eps Estimate |
Eps Actual |
Prev-Year Actual |
Date/Time (ET) |
---|---|---|---|---|
Q2 2024 | 0.80 | n.a. | 0.64 | 30-Jun-24 |